NASDAQ: EDIT       Editas Medicine
Last Price Today's Change   Day's Range   Trading Volume
29.80   -0.33 (1.10%)  29.59 - 30.557  600,029


Avg Volume (4 weeks):1,364,098
4 Weeks Range:22.51 - 31.78
4 Weeks Price Volatility (%):
52 Weeks Range:17.80 - 31.78
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Editas Medicine Inc is a US-based genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company operates its business in a single segment of Developing and commercializing genome editing technology.

  Be the first to like this.


2573  3165  319  2910 

Top 10 Active Counters
 CELG 108.24+0.11 
 AMD 41.27-1.32 
 CHK 0.782-0.001 
 DHR 148.795-2.505 
 AABA 19.630.00 
 GE 11.355-0.085 
 VIAB 24.22+0.75 
 BAC 34.455-0.225 
 NIO 2.395+0.125 
 F 9.22-0.10 
Partners & Brokers